The Chemours Company (CC) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

The Chemours Company (CC) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

CC

Market Closed

The Chemours Company

NYSEBasic Materials Chemicals - Specialty

5.70K employees

CEO: Denise Dignam

Founded: 2015

$17.22

+$0.00(+NaN%)

Market Cap

2.59B

Beta

1.40

52W Range

N/A

Dividend Yield

2.03%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: The Chemours Company’s current price at $17.52 is significantly below the PERT-weighted fair value of $26.42, indicating potential undervaluation with a high confidence level. However, poor financial health scores and high volatility (58.36% coefficient of variation) signal elevated risk. Monte Carlo analysis reveals broad value dispersion, with downside risk at 16.7% but upside potential exceeding 100%.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore CC

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples